Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans Grosse-Wilde is active.

Publication


Featured researches published by Hans Grosse-Wilde.


Cellular and Molecular Life Sciences | 2011

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger

Although the expression of the non-classical HLA class I molecule HLA-G was first reported to be restricted to the fetal–maternal interface on the extravillous cytotrophoblasts, the distribution of HLA-G in normal tissues appears broader than originally described. HLA-G expression was found in embryonic tissues, in adult immune privileged organs, and in cells of the hematopoietic lineage. More interestingly, under pathophysiological conditions HLA-G antigens may be expressed on various types of malignant cells suggesting that HLA-G antigen expression is one strategy used by tumor cells to escape immune surveillance. In this article, we will focus on HLA-G expression in cancers of distinct histology and its association with the clinical course of diseases, on the underlying molecular mechanisms of impaired HLA-G expression, on the immune tolerant function of HLA-G in tumors, and on the use of membrane-bound and soluble HLA-G as a diagnostic or prognostic biomarker to identify tumors and to monitor disease stage, as well as on the use of HLA-G as a novel therapeutic target in cancer.


Annals of Hematology | 1976

T-Zell-Leukämien des Erwachsenen

D. Huhn; Hans V. Rodt; Eckhard Thiel; Hans Grosse-Wilde; U. Fink; Hans Theml; Gundula Jäger; Christoph Steidle; Stefan Thierfelder

Zusammenfassung9 erwachsene Patienten mit vom T-Zellsystem ausgehenden lymphatischen Systemerkrankungen wurden untersucht: 4 Patienten mit T-ALL; 1 T-ALL-CLL-Mischform; 2 T-CLL; 2 Sézary-Syndrom. Die klinischen Besondernheiten der verschiedenen Leukämieformen wurden verglichen, morphologische und zytochemische Befunde beschrieben. Die T-Zelleigenschaft der jeweiligen malignen Zellpopulation sowie die B- und T-Zellzusammensetzung der morphologisch normalen Rest-Lymphozytenpopulation wurden durch folgende Zellmarker festgestellt: Nachweis von T-Zellantigen bzw. Membranimmunglobulin durch spezifische heterologe Antiseren, konjugiert mit Peroxidase,125Jod oder Fluoreszein; KBR oder Zytotoxizität durch derartige Antiseren; spontane Rosettenbildung mit Schaferythrozyten oder mit Acrylsäure-Perlen. Die Stimulierbarkeit der malignen Zellen, bzw. der restlichen, morphologisch normalen Zellen durch pflanzliche Mitogene oder allogene Zellen wurde geprüft. Unter Berücksichtigung aller Befunde stellen die T-Zell-Leukämien des Erwachsenen eine besondere Krankheitsgruppe dar, deren einzelne Unterformen Gemeinsamkeiten und fließende Übergänge aufweisen.Summary9 adult patients suffering from different forms of T-cell-malignancies were investigated: 4 patients with T-ALL; 1 T-ALL-CLL mixed form (prolymphocytic); 2 T-CLL; 2 Sézary-syndrome. The clinical peculiarities of the different forms of leukemias were compared: involvement of lymph nodes and spleen, of the central nervous system and the skin was frequent; in contrast to the findings in Sézarysyndrome, bone marrow infiltration was prominent. Light and electron microscopic morphology of the malignant cells are described. In all cases a strong activity of acid phosphatase was demonstrated, in one patient prominent deposits of glycogen. The T-cell-quality of the respective malignant cell population as well as the B-T-cell distribution of the remaining “normal” lymphocytes were shown by the following cell markers: demonstration of T-cell-antigen, resp. membrane immunoglobulins with the aid of specific heterologous antisera conjugated with peroxidase,125iodine or fluoresceine; complement cons umtion or cytotoxicity with such antisera; spontaneous rosette formation with sheep red ceils or with acrylic acid beads. Usually, there was a good coincidence in results obtained with the different markers. In two patients, however, T-cells demonstrated by anti-T-globulin were not able to form T-rosettes. Responsiveness of the malignant T-cells and also of the remaining „normal“ blood lymphocytes to different mitogens usually was depressed, immunoglobulin levels in the blood mostly were normal.Taking all findings into consideration, T-cell-leukemias of the adult represent a special group of hematological malignancies; the different subgroups show similarities; transitional forms occur.


Zeitschrift für Immunitätsforschung: Immunobiology | 1977

HLA-D Typing with Homozygous Lymphoblastoid Cell Lines

B. Netzel; G. Bornkamm; V. Lenhard; Siegfried Scholz; Hans Grosse-Wilde

Lymphoblastoid cell lines (LCL) was established from peripheral blood lymphocytes (PBL) of 2 HLA-DW 3 homozygous siblings. HLA-D typing was performed with the homozygous LCL and PBL in a group of 51 unrelated individuals selected according to their HLA-A,B locus antigens. All the individuals who were typed positive for DW3 with PBL typing cells could also be typed positive with the LCL typing cells. Both homozygous LCL behave very similarly in the tested population. These experiments showed that the same HLA-D determinants were represented both on LCL and PBL cells and that LCL derived from MLC homozygous donors can be used for HLA-D typing.


Annals of Hematology | 1977

Hematologic and immunologic studies in dogs given nitrogen mustard (HN3)

J. Abb; B. Netzel; Hans V. Rodt; Hans Grosse-Wilde; N. Weger; Stefan Thierfelder

SummaryHématologic and immunosuppressive effects of single doses of nitrogen mustard (HN3) were evaluated in 20 dogs. HN3 caused profound depression of peripheral blood counts in all animals. Recovery of total white blood cell counts in dogs surviving the acute gastrointestinal toxicity of HN3 was complete by day 15. Recovery of platelet and lymphocyte counts to initial levels took a more prolonged course.Granulopoietic progenitor cells (CFU-C) in the bone marrow were assayed by an in vitro culture system. Concentrations of CFU-C were markedly decreased one day after HN3-treatment, but showed at near-lethal doses rapid restoration to normal values within 4 to 7 days.Cellular immune function of HN3-treated dogs was impaired for prolonged periods as indicated by the reduced capacity of canine lymphocytes to prolifferate in vitro in response to stimulation with mitogens. Humoral immune function was similarly affected as determined by the depressed and delayed antibody formation against an intravenous challenge with sheep red blood cells.In conclusion, our results suggest a different effect of HN3 on lymphoid and myeloid precursor cells.ZusammenfassungHämatologische und immunsuppressive Wirkung von einmaligen Stickstofflost(HN3)-Gaben wurde an 20 Hunden untersucht. HN3 verursachte bei allen Tieren eine starke Erniedrigung der peripheren Blutwerte. Bei Hunden, die die akute gastrointestinale Toxizität von HN3 überlebten, war die Erholung der Gesamtleukozyten am Tag 15 vollständig. Die Wiederherstellung der Ausgangswerte von Thrombozyten und Lymphozyten nahm einen protrahierteren Verlauf.Granulopoetische Vorläuferzellen (CFU-C) im Knochenmark wurden durch in vitro Kulturen bestimmt. Die CFU-C-Konzentrationen waren einen Tag nach der Behandlung mit HN3 deutlich vermindert, zeigten aber selbst nach nahezu letalen Dosen schnelle Regeneration zu Normalwerten innerhalb 4 bis 7 Tagen.Die reduzierte Fähigkeit von Hundelymphozyten, nach Stimulation mit Mitogenen in vitro zu proliferieren, wies auf eine langanhaltende Beeinträchtigung der zellulären Immunfunktion bei HN3-behandelten Hunden hin. Die humorale Immunfunktion war ähnlich betroffen, wie sich aus der verminderten und verzögerten Bildung von Antikörpern gegen Schaferythrozyten ergab.Zusammenfassend lassen unsere Ergebnisse eine unterschiedliche Wirkung von HN3 auf lymphatische und myeloische Vorläuferzellen vermuten.


Annals of Hematology | 1973

Identity for the strong MLC-locus in HL-A different unrelated pairs.

W. Mempel; Hans Grosse-Wilde; Ekkehard D. Albert

SummaryTwo pairs of unrelated persons were found who were HL-A serologically different but showed no stimulation in the Mixed Lymphocyte Culture (MLC) test. This finding supports the hypothesis of an independent genetic system which codes for MLC reactivity. The reaction patterns against either sibling of one of the partners or HL-A identical unrelated persons are described.ZusammenfassungZwei Paare von nichtverwandten Personen konnten gefunden werden, die, obwohl sie serologisch HL-A-different waren, sich gegenseitig nicht im MLC-Test anregten. Die Theorie eines eigenen genetischen Systems für das Verhalten in der Gemischten Lymphozytenkultur (MLC) erhält damit weitere Unterstützung. Die Reaktionsweisen der Zellen dieser beiden Paare gegen Zellen von Geschwistern eines Partners oder gegen Zellen von nichtverwandten Personen, die mit einem Partner HL-A-identisch waren, wurden beschrieben.


Tissue Antigens | 2001

Association of soluble HLA-G plasma levels with HLA-G alleles.

Vera Rebmann; K. Ven; M. Päßler; K. Pfeiffer; D. Krebs; Hans Grosse-Wilde


Tissue Antigens | 1999

Detection of soluble HLA‐G molecules in plasma and amniotic fluid

V. Rebmann; K. Pfeiffer; M. Päßler; Soldano Ferrone; S. Maier; Elisabeth H. Weiss; Hans Grosse-Wilde


Kidney International | 1974

Vitamin B6 deficiency in uremia and its implications for the depression of immune responses

Hendrik Dobbelstein; Wilhelm F. Körner; W. Mempel; Hans Grosse-Wilde; H. H. Edel


Tissue Antigens | 1993

Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992

Philippe Jacques Pouletty; Soldano Ferrone; Française Amesland; Nadine Cohen; Ulriko Westhoff; Dominique Charron; Robert M. Shimizu; Hans Grosse-Wilde


Tissue Antigens | 2003

Specificity and functional characteristics of anti‐HLA‐A mAbs LGIII‐147.4.1 and LGIII‐220.6.2

Xinhui Wang; Bitao Liang; Vera Rebmann; Jun Lu; Esteban Celis; Toshiro Kageshita; Hans Grosse-Wilde; Soldano Ferrone

Collaboration


Dive into the Hans Grosse-Wilde's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vera Rebmann

University of Duisburg-Essen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bitao Liang

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun Lu

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshiro Kageshita

Roswell Park Cancer Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge